Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berges

Showing results (721-730 of 891) with videos related to

Pageof 90
Sort By:
International Urology and Nephrology|January 29, 2013
Prevalence of abnormal urinary albumin excretion in elderly people: a Spanish surveyN R Robles, F J Felix, D Fernandez-Berges, et al.
Current Alzheimer Research|December 24, 2013
A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's diseaseRichard A Grove, Conn M Harrington, Andreas Mahler, et al.
British Journal of Haematology|April 7, 1999
Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALLJ Ciudad, J F San Miguel, M C López-Berges, et al.
ACS Applied Materials & Interfaces|September 8, 2018
High-Vacuum Particulate-Free Deposition of Wafer-Scale Mono-, Bi-, and Trilayer Molybdenum Disulfide with Superior Transport PropertiesKortney Almeida, Michelle Wurch, Adane Geremew, et al.
Mucosal Immunology|March 29, 2022
Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responsesJens Wittner, Sebastian R Schulz, Tobit D Steinmetz, et al.
European Review for Medical and Pharmacological Sciences|July 24, 2013
The HUGE formula (hematocrit, urea and gender): association with cardiovascular riskN R Robles, F J Felix, D Fernandez-Berges, et al.
Molecular Cancer Therapeutics|July 2, 2014
EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion proteinDmitrij Hristodorov, Manal Amoury, Radoslav Mladenov, et al.
Therapeutic Innovation & Regulatory Science|February 11, 2022
Ivermectin in COVID-19: The Case for a Moratorium on PrescriptionsAndreea Molnar, Stephanie Lau, Maja Berges, et al.
Transfusion|May 22, 1998
Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantationJ A Pérez-Simón, M D Caballero, M Corral, et al.
The Journal of Antibiotics|January 1, 1976
Orally active 7-phenylglycyl cephalosporins. Structure-activity studies related to cefatrizine (SK&F 60771)G L Dunn, J R Hoover, D A Berges, et al.
Pageof 90

Showing results (721-730 of 891) with videos related to

Sort By:
Pageof 90
International Urology and Nephrology|January 29, 2013
Prevalence of abnormal urinary albumin excretion in elderly people: a Spanish surveyN R Robles, F J Felix, D Fernandez-Berges, et al.
Current Alzheimer Research|December 24, 2013
A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's diseaseRichard A Grove, Conn M Harrington, Andreas Mahler, et al.
British Journal of Haematology|April 7, 1999
Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALLJ Ciudad, J F San Miguel, M C López-Berges, et al.
ACS Applied Materials & Interfaces|September 8, 2018
High-Vacuum Particulate-Free Deposition of Wafer-Scale Mono-, Bi-, and Trilayer Molybdenum Disulfide with Superior Transport PropertiesKortney Almeida, Michelle Wurch, Adane Geremew, et al.
Mucosal Immunology|March 29, 2022
Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responsesJens Wittner, Sebastian R Schulz, Tobit D Steinmetz, et al.
European Review for Medical and Pharmacological Sciences|July 24, 2013
The HUGE formula (hematocrit, urea and gender): association with cardiovascular riskN R Robles, F J Felix, D Fernandez-Berges, et al.
Molecular Cancer Therapeutics|July 2, 2014
EpCAM-selective elimination of carcinoma cells by a novel MAP-based cytolytic fusion proteinDmitrij Hristodorov, Manal Amoury, Radoslav Mladenov, et al.
Therapeutic Innovation & Regulatory Science|February 11, 2022
Ivermectin in COVID-19: The Case for a Moratorium on PrescriptionsAndreea Molnar, Stephanie Lau, Maja Berges, et al.
Transfusion|May 22, 1998
Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantationJ A Pérez-Simón, M D Caballero, M Corral, et al.
The Journal of Antibiotics|January 1, 1976
Orally active 7-phenylglycyl cephalosporins. Structure-activity studies related to cefatrizine (SK&F 60771)G L Dunn, J R Hoover, D A Berges, et al.
Pageof 90